| Event chart SAMSUNG BIOLOGICS CO.,LTD. |
|
|
|
| Upcoming events on SAMSUNG BIOLOGICS CO.,LTD. |
|
| 08/16/22 | | Interim 2022 Earnings Release (Projected) |
| 10/25/22 | | Q3 2022 Earnings Release (Projected) |
| 03/09/23 | | FY 2022 Earnings Release (Projected) |
| 04/26/23 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on SAMSUNG BIOLOGICS CO.,LTD. |
|
| 04/27/22 | 02:42am | | Q1 2022 Earnings Release |
| 03/28/22 | | Annual General Meeting |
| 01/24/22 | 03:25am | | FY 2021 Earnings Release |
| 01/10/22 | | JP Morgan Healthcare Conference |
| 10/26/21 | 03:23am | | Q3 2021 Earnings Release |
| 08/17/21 | | Interim 2021 Earnings Release |
| 05/17/21 | | Q1 2021 Earnings Release |
| 03/11/21 | | FY 2020 Earnings Release |
| 01/09/19 | 06:30pm | | J.P. Morgan Healthcare Conference |
| 01/10/18 | 04:30pm | | J.P. Morgan Health Care Conference |
|
| Past dividends on SAMSUNG BIOLOGICS CO.,LTD. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
B KRW |
Released
Forecast
Spread | 465
437
6,3% | 536
498
7,6% | 702
602
17% | 1 165
1 067
9,2% |
1 554
|
1 981
|
Operating income
(EBITDA)
B KRW |
Released
Forecast
Spread | 136
120
13% | 147
156
-5,8% | 220
164
34% | 430
403
6,7% |
683
|
856
|
Operating profit
(EBIT)
B KRW |
Released
Forecast
Spread | 66,0
39,2
68% | 55,7
66,1
-16% | 91,7
30,1
204% | 293
279
4,9% |
534
|
685
|
Pre-Tax Profit
(EBT)
B KRW |
Released
Forecast
Spread | -116
-107
-8,3% | 303
324
-6,6% | 155
48,1
223% | 266
288
-7,5% |
591
|
767
|
Net income
B KRW |
Released
Forecast
Spread | -97,0
-80,8
-20% | 224
240
-6,8% | 203
44,8
353% | 241
227
5,9% |
437
|
538
|
EPS
KRW |
Released
Forecast
Spread | -1 466
-1 278
-15% | 3 387
3 663
-7,5% | 3 067
654
369% | 3 793
3 437
10% |
6 611
|
7 785
| | Announcement Date | 01/31/2018 | 01/31/2019 | 01/22/2020 | 01/26/2021 | 01/24/2022 | - |
|
|
|
| Fiscal Period : December | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
Sales
B KRW |
Released
Forecast
Spread | 313
208
50% | 207
218
-5,1% | 308
239
29% | 275
247
11% | 375
278
35% | 261
289
-9,6% | 412
376
9,5% | 451
406
11% |
436
|
464
|
|
|
|
Operating income
(EBITDA)
B KRW |
Released
Forecast
Spread |
| 95,5
81,4
17% |
|
|
|
|
162
|
|
|
|
|
|
|
Operating profit
(EBIT)
B KRW |
Released
Forecast
Spread | 107
45,0
138% | 62,6
37,9
65% | 81,1
62,0
31% | 56,8
62,5
-9,2% | 92,3
61,0
51% | 74,3
74,2
0,20% | 167
114
46% | 167
134
25% |
142
|
152
|
|
|
|
Pre-Tax Profit
(EBT)
B KRW |
Released
Forecast
Spread | 167
61,0
175% | 65,2
54,9
19% | 77,9
99,0
-21% | 52,5
73,2
-28% | 70,4
105
-33% | 81,7
92,4
-12% | 165
130
27% | 197
147
34% |
175
|
170
|
|
|
|
Net income
B KRW |
Released
Forecast
Spread | 211
54,0
290% | 50,1
49,9
0,59% | 52,0
72,8
-29% | 40,0
57,6
-31% | 98,8
77,5
28% | 62,4
71,8
-13% | 130
93,6
38% | 132
105
26% |
121
|
129
|
|
|
|
EPS
KRW |
Released
Forecast
Spread |
|
|
| 605
4 331
-86% | 1 528
4 263
-64% | 943
| 1 957
1 306
50% |
|
1 890
|
1 820
|
1 468
|
1 793
|
1 677
| | Announcement Date | 01/22/2020 | 04/20/2020 | 07/21/2020 | 10/21/2020 | 01/26/2021 | 04/28/2021 | 07/27/2021 | 10/26/2021 | 01/24/2022 | 04/27/2022 | - | - | - | |
|
|
| Upcoming sector events for SAMSUNG BIOLOGICS CO.,LTD. |
|
| |
|
| Past sector events for SAMSUNG BIOLOGICS CO.,LTD. |
|
| |
|
|
|
|
COVID vaccine maker Moderna flags Japan ambition with sumo sponsorship |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
